Clinical Trial

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

Recruiting
View on ClinicalTrials.gov →
Summary
Monitoring of antimicrobial resistance (AMR) based on metagenomics analyses in pneumonia patients is critical for optimizing clinical diagnosis and treatment and improving clinical prognosis. This study is designed to ask the following key questions: 1. What is the microbiome maps of patients with severe pneumonia and mild pneumonia ? 2. How many pathogen resistance genes are carrying in severe pneumonia and mild pneumonia ? 3. What is the genetic diversity of key pathogens detected in severe pneumonia and mild pneumonia during 2019-2025?
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-20.
Trial Details
NCT Number NCT06566898
Lead Sponsor Shanghai General Hospital, China
Collaborators: Wuxi People's Hospital Affiliated to Nanjing Medical University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, The Central Hospital of Huanggang
Conditions Pneumonia, Next-generation Sequencing, Microbiome, Antimicrobial Resistance
Enrollment 800 participants
Start Date 2024-08-01
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-23